Medications, By Class, in TBI

Size: px
Start display at page:

Download "Medications, By Class, in TBI"

Transcription

1 Medications, By Class, in TBI Generic/Brand Name Drawback Advantage Mood Stabilizers (anti-seizure medications) Carbamazepine (Carbatrol ) (Equetro ) (Tegretol ) Gabapentin (Neurontin ) Lamotrigine (Lamictal ) Levetiracetam (Keppra) Some anticholinergic effects. Blood tests with relatively narrow therapeutic window. Affects the blood levels of many medications and vice versa. Rare risk of serious rash Sedating early Multiple daily dosing Very slow titration 5% risk of rash Rare but real risk of serious rash May induce hostility or aggression, especially at low dose Some antidepressant effects. Minor negative neurological effects. Renal excretion (very few medications are) so useful in hepatic illness Anti-anxiety without the negative neurological consequences of benzodiazepines Neuropathic pain decrease Has antidepressant properties (stabilizes from below) Has neuroprotective properties (anti-glutaminergic) Very few side effects No blood tests needed, but can be done to guide high dosing (target 6) Does not have much impact on other medications because of renal excretion Overall mood elevating/activating Oxcarbazepine (Trileptal ) More frequent effects on sodium (hyponatremia) Rare but real risk of serious rash Does not have much impact on other medications compared with carbamazepine September 24,

2 Pregabalin (Lyrica) Somewhat sedating Neuropathic pain decrease Tiagabine (Gabitril) Somewhat sedating Can have reverse effects Can cause seizures Antianxiety without the negative neurological effects of benzodiazepine. Topiramate (Topamax) Valproate (Depakote ) (Depakene ) Negative cognitive effects require dose limitation and slow titration Weight gain (lack of satiety) Hair loss It can raise ammonia levels and have neurotoxic effects. Neuropathic and migraine pain relief Cognitive enhancement Appetite suppressant Rapid titration Good for aggression Blood levels meaningful Zonisamide (Zonegran ) Relatively slow titration Neuropathic pain control Stimulants/ADD Treatment Catacholaminergic Medications (norepinephrine and dopamine) Methylphenidate (Ritalin ) (Metadate ) (Concerta ) Potential for abuse Short acting form requires multiple dosing Long experience Diffuse activation of the brain Short acting means no adverse impact on sleep Dextroamphetamine (Dexedrine ) Greater abuse potential More potent Mixed Catacholaminergic Salts (Adderall ) Greater abuse potential Usually smoother effect in ABI Modafinil (Provigil ) Kinder gentler stimulant September 24,

3 Bupropion (Wellbutrin ) (Zyban ) Atomoxetine (Strattera ) Amantadine (Symmetrel ) Pramipexole (Mirapex ) Ropinirole (Requip ) Some seizure risk (although when used properly not really more than other meds) Provides general activation with long half-life so sleep can be impaired Slow titration Hepatic dysfunction Can trigger paranoia Can trigger paranoia Associated with weight gain Can trigger paranoia No abuse potential Antidepressant effects Anti-addiction effects Avoids abuse potential of stimulants. Avoids the tic potential of stimulants Decreases motor restlessness Decreases centrally induced motor stiffness Prevents influenza! Decreases motor restlessness Decreases centrally induced motor stiffness Mood elevator Decreases motor restlessness Decreases centrally induced motor stiffness Mood elevator SSRI's (selective serotonin reuptake inhibitors) All SSRI s Paroxetine (Paxil ) Sexual inhibition, especially delay in orgasm Neurasthenia (fatigue without structure in afternoon) Discontinuation syndrome (flu like symptoms as blood level drops) GI effects; especially early Most sedating Some anticholinergic effects Discontinuation syndrome No independent suicide potential Decrease anger (negative side is an increase in apathy) Sedation can improve agitation early More useful for nightmares September 24,

4 Sertraline (Zoloft ) Citalopram (Celexa ) Escitalopram (Lexapro ) Fluoxetine Most stimulating Can have pseudo akathisia Neutral between sedating and activating Rather specific for serotonin Even more specific. The dextro isomer, escitalopram, is the active ingredient in citalopram Long half-life means no discontinuation syndrome SSRI + Stimulant (serotonergic and catacholaminergic) Duloxetine (Cymbalta ) Venlafaxine (Effexor ) Desmethyl venlafaxine (Pristiq ) SSRI side effects with more GI side effects GI side effects (much less with sustained release form Requires high dose (>225 mg/day) to get noradrenergic effect Provides effects similar to both bupropion and SSRI even at low dose More analgesic effect than the SSRI s Provides effects similar to both Bupropion and SSRI More analgesic effect than the SSRI s Sedative/Antianxiety (gabaminergic) Zolpidem (Ambien ) Zaleplon (Sonata ) Eszopiclone (Lunesta ) Expensive (except generic zolpiden) Partial γ-amino butyric acid agonism. (older benzodiazepines are full agonists) leading to minimal if any negative neurological effects Short half-life means no hangover Buspirone (Buspar ) Actually 5-HT1a agonism and D2 antagonism Very gradual effects Decrease bruxism Excellent top-off for agitation September 24,

5 SGA s (Second Generation Antipsychotics) Also called: Broad Spectrum Psychotropics Risperidone (Risperdal ) Paliperidone (Invega ) Has mild D 2 blocking effects Orthostatic hypotension Most like older antipsychotics Most impact on prolactin Rapid onset Olanzapine (Zyprexa ) CHO craving can lead to weight gain and metabolic syndrome Mild anticholinergic effects - especially peripheral Mood elevating Calming Quetiapine (Seroquel ) (Seroquel XR ) Sedating Short half-life, but new XR formulation is ideal for HS dosing Very calming No D 2 blocking effect Neuroprotective (cortisol suppressed) Ziprasidone (Geodon ) Has to be taken with food Can affect cardiac conduction (fear more than reality) Can be activating Sedative effect can be used too No D 2 blocking effect Neuroprotective (cortisol suppressed) Aripiprazole (Abilify ) A new class of partial agonist, but used like the SGA s Early nausea and vomiting Early EPS (akathisia and dystonia) Early activation Weight neutral Minimal prolactinemia Long half-life Others Trazodone (Desyrel ) Hypotension Non-benzodiazepine, nonaddicting, no negative neurological effects Mirtazapine (Remeron ) Sedating Weight Gain Can double as sleeper Benefit for cephalgia Not sexually inhibiting Nefazodone (Serzone ) Weak antidepressant Occasional hepatic failure Helps anxiety Good for PTSD type nightmares Not sexually inhibiting September 24,

6 Lithium Carbonate (Lithobid ) and others Blood levels with narrow therapeutic window Some negative neurological impact Weight gain from H 2 O retention Effective for classical bipolar type symptoms Effective for aggression Donepezil (Aricept ) Galantamine (Reminyl ) (Razadyne ) (Nivalin ) Can worsen asthma Multiple drug interactions Effect usually quite small (cortical dementia) Blocks acetylcholinesterase which decreases acetylcholine Rivastigmine (Exelon ) Memantine (Namenda ) Activation (can be a benefit) NMDA antagonist (neuroprotective), especially with stress. Helps with cognition more than memory (subcortical). Neutriceuticals Omega-3 Fatty Acids (Omacor ) (CorOmega ) and others. Target 1800 mg of EPA Can increase bleeding (blood thinner) Fish burps Oily Stools Stabilizes mood Delays dementia Increase cognitive flexibility (IQ) Decreases anger (especially sudden) Decreases stroke/heart attack Curcumin, Turmeric, Saffron Decreases neurodegenerative disorders by blunting oxidation (free radicals) Huperzine A (Chinese cold moss) Natural Cholanesterase Inhibitor September 24,

Schedule FDA & literature based indications

Schedule FDA & literature based indications Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

New Patient Questionnaire

New Patient Questionnaire 4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution

More information

PSYCHIATRY INTAKE FORM

PSYCHIATRY INTAKE FORM Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150

More information

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA *We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening

More information

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient

More information

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care?

Happy Daisy Ltd. New Client intake Form. What are the issues for which you are seeking care? Happy Daisy Ltd. New Client intake Form Name Date Preferred name Pronouns Referred by Date of birth Age Race What are the issues for which you are seeking care? 1. 2. 3. Please check of any of the symptoms

More information

Appendix: Psychotropic Medication Reference Tables

Appendix: Psychotropic Medication Reference Tables Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

Mental Health Intake Form

Mental Health Intake Form 38600 Van Dyke Ave., Suite 200 Sterling Heights, MI 48313 Phone: (586) 933-5395 Fax: (586) 935-0159 Mental Health Intake Form Please complete all information on this form and bring it to the first visit.

More information

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:

More information

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

More information

2015 Update on Psychotropics

2015 Update on Psychotropics 2015 Update on Psychotropics Jeffrey T. Apter, M.D. August 2015 Princeton Medical Institute 256 Bunn Drive, Suite 6, Princeton NJ (609) 921-6050 Learning Objectives Upon completion of this session, participants

More information

Mental Health Intake Form

Mental Health Intake Form Current Symptoms Checklist: (check once for any symptoms present, twice for major symptoms) ( ) ( ) Depressed mood ( ) ( ) Racing thoughts ( ) ( ) Excessive worry ( ) ( ) Unable to enjoy activities ( )

More information

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine

More information

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting

More information

NEW PATIENT INTAKE FORM

NEW PATIENT INTAKE FORM NEW PATIENT INTAKE FORM Please fill out the following form to the best of your ability. Some sections may not apply to you. We will discuss your responses in greater detail during your first appointment.

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

Psychiatric Medication Guide

Psychiatric Medication Guide Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants

More information

Moderator: Michele Y. Splinter, Pharm.D., BCPS Clinical Associate Professor, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma

Moderator: Michele Y. Splinter, Pharm.D., BCPS Clinical Associate Professor, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma Central Nervous System PRN Focus Session Management of the Patient with Traumatic Brain Injury Activity No. 0217-0000-11-102-L01-P (Knowledge-Based Activity) Tuesday, October 18 3:30 p.m. 5:30 p.m. Convention

More information

Expected Outcomes. Assumptions. Borderline Personality Disorder: Pharmacologic Intervention

Expected Outcomes. Assumptions. Borderline Personality Disorder: Pharmacologic Intervention Borderline Personality Disorder: Pharmacologic Intervention Barbara J. Limandri, DNSc, APRN, BC Associate Professor Linfield College School of Nursing PMHNP Portland Dialectical Behavior Therapy Program

More information

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 This power point is only a guideline for recommendations in the treatment of psychiatric disorders. This is not comprehensive. Please

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

Psychotropic Strategies Handout Package

Psychotropic Strategies Handout Package Psychotropic Strategies Handout Package Psychotropic Strategies Learning Objectives Utilize all clinical information available Assess the patient s overall condition this is essential Basic Principles

More information

Psychopharmacology: An Overview

Psychopharmacology: An Overview Psychopharmacology: An Overview John Tanquary, M.D. Clinical Assistant Professor Department of Psychiatry Upstate Medical University Psychpharmacology Consultant Le Moyne College Syracuse University Financial

More information

Quick Guide to Common Antidepressants-Adults

Quick Guide to Common Antidepressants-Adults Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa

More information

Dealing with a Mental Health Crisis

Dealing with a Mental Health Crisis Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to

More information

Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016

Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Good psychopharmacology depends on Proper use of safe and effective meds Treatment of other obvious factors (e.g., medical conditions, toxic

More information

USF Health Psychiatry Clinic. New Patient Questionnaire Adult

USF Health Psychiatry Clinic. New Patient Questionnaire Adult USF Health Psychiatry Clinic New Patient Questionnaire Adult Please mail or fax the completed forms to the address/fax number on the bottom of this page. Completed forms must be received five (5) days

More information

Psychotropic Medications in Children and Adolescents: Guide for Use and Monitoring

Psychotropic Medications in Children and Adolescents: Guide for Use and Monitoring Psychotropic Medications in Children and Adolescents: Guide for Use and This document was developed by Community Care of North Carolina with the assistance of the Medication Management Workgroup of the

More information

Barbara J. Limandri, DNSc, APRN, BC 1

Barbara J. Limandri, DNSc, APRN, BC 1 Barbara J. Limandri, DNSc, APRN, BC Linfield College Portland Dialectical Behavior Therapy Program At the conclusion of this workshop, the participant can: 1. Associate key regions of the brain with psychiatric

More information

CONTRAINDICATIONS TABLE

CONTRAINDICATIONS TABLE CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis

More information

Barbara J. Limandri, DNSc, APRN, BC Linfield College Portland Dialectical Behavior Therapy Program

Barbara J. Limandri, DNSc, APRN, BC Linfield College Portland Dialectical Behavior Therapy Program Barbara J. Limandri, DNSc, APRN, BC J,,, Linfield College Portland Dialectical Behavior Therapy Program At the conclusion of this workshop, the participant i t can: 1. Associate key regions of the brain

More information

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

Supplement: Tables and Figures

Supplement: Tables and Figures Supplement: Tables and Figures Supplement Table 1. Baseline Characteristics by Study and Efavirenz Assignment Supplement Table 2. Baseline Psychoactive Medications by Efavirenz Assignment* Supplement Table

More information

MO Medicaid Foster Care Drugs FY10-FY14

MO Medicaid Foster Care Drugs FY10-FY14 MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri

More information

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get

More information

NorthSTAR. Pharmacy Manual

NorthSTAR. Pharmacy Manual NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics

More information

Tourette Syndrome. Biological Basis, Clinical Symptoms, Treatment. Drake D. Duane, MS, MD

Tourette Syndrome. Biological Basis, Clinical Symptoms, Treatment. Drake D. Duane, MS, MD Tourette Syndrome Biological Basis, Clinical Symptoms, Treatment Drake D. Duane, MS, MD Director, Institute for Developmental Behavioral Neurology Adjunct Professor, Arizona State University Scottsdale/Tempe,

More information

John Roberts, MD Addiction Psychiatrist Pavillon. Studies. Co-Occurring Disorders are the expectation rather than the exception

John Roberts, MD Addiction Psychiatrist Pavillon. Studies. Co-Occurring Disorders are the expectation rather than the exception Prevalence John Roberts, MD Addiction Psychiatrist Pavillon Approximately 5 million US Adults have a serious mental illness and a cooccurring substance use disorder (SAMHSA,2006) Mental health settings

More information

New Patient Packet. Drake D. Duane, MS, MD. Drake D. Duane, MS, MD. Patient Name:

New Patient Packet. Drake D. Duane, MS, MD. Drake D. Duane, MS, MD. Patient Name: Institute for Behavioral Neurology New Patient Packet Patient Name: Institute for Behavioral Neurology NEW PATIENT INFORMATION FORM PATIENT INFORMATION PATIENT FULL NAME: TODAY S DATE: DOB: AGE: MARITAL

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

Mood Disorders.

Mood Disorders. Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner

More information

Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you.

Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you. Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you. In order to make the most of your first appointment, please come at least 30 minutes prior

More information

Psychiatry in Primary Care: What is the Role of Pharmacist?

Psychiatry in Primary Care: What is the Role of Pharmacist? Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure

More information

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty

More information

Steps for Initiating Electroconvulsive Therapy Treatment

Steps for Initiating Electroconvulsive Therapy Treatment Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral

More information

2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources

2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources Drugs and Dementia in the Hospice Patient Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources 1 Drug Therapy: Targeted at Symptoms Cognitive: Impaired abstract thinking Impaired

More information

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY 13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD

More information

WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together. Presented by

WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together. Presented by WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together Presented by Our agenda for today Understanding behavioral symptoms in people living with dementia Briefly review key strategies

More information

Use of Psychotropic Medications in Older Adults with Dementia!

Use of Psychotropic Medications in Older Adults with Dementia! Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with

More information

Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities

Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities One definition of polypharmacy is using more medications than is medically necessary. However, it can be

More information

The Confusion of Old Age: the relationship of dementia, depression, and agitation to executive dysfunction in the elderly

The Confusion of Old Age: the relationship of dementia, depression, and agitation to executive dysfunction in the elderly The Confusion of Old Age: the relationship of dementia, depression, and agitation to executive dysfunction in the elderly William B. Orr, Ph.D., M.D. Orr Memory William and B. Geriatric Orr, Ph.D., Behavioral

More information

Creating Partnerships. Laine Young-Walker, MD

Creating Partnerships. Laine Young-Walker, MD Creating Partnerships Laine Young-Walker, MD Psychiatry is the medical specialty devoted to the study, diagnosis, treatment and prevention of mental disorders. Medical school >>>four years of residency

More information

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG NAME. Use Brand Only ACAMPROSATE TABLET DELAYED RELEASE ALPHA-TOCOPHEROL CAPSULES ALPRAZOLAM CONCENTRATE 1 MG/ML ALPRAZOLAM ODT TABLET 0.25MG, 0.5MG, 1MG ALPRAZOLAM ODT TABLET 2MG ALPRAZOLAM SR TABLET 24-HOUR ALPRAZOLAM TABLET

More information

Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED

Use Brand Only. Preferred Drug Status PRIOR AUTHORIZATION REQUIRED Generic Drugs Are Over Brand Drugs Unless Specified As Brand ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE REMERON 30 30 MIRTAZAPINE REMERON SOLTAB 30 30 ISOCARBOXAZID TABLETS

More information

Management of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*

Management of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors* Management of SSRI Induced Sexual Dysfunction John J. Miller, M.D. Medical Director, Center for Health and WellBeing Exeter, NH Serotonin Reuptake Inhibitors* fluoxetine clomipramine sertraline paroxetine

More information

med ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.

med ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors. med ed Dr. Andrea Murphy, Assistant Professor, School of Nursing, Dalhousie University; Research Associate, Sun Life Financial Chair in Adolescent Mental Health Dr. David Gardner, Associate Professor,

More information

Things You Might Not Know About Psychotropic Medications But Wish You Did

Things You Might Not Know About Psychotropic Medications But Wish You Did Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and

More information

Adult Initial Assessment / Patient Questionnaire Page 1

Adult Initial Assessment / Patient Questionnaire Page 1 Page 1 Patient Name: Date: Age: Date of Birth: / / Please read the following questions and answer to the best of your ability by placing a checkmark in the appropriate boxes or filling in the blank as

More information

Dual Diagnosis: Substance Abuse and Mental Illness

Dual Diagnosis: Substance Abuse and Mental Illness Dual Diagnosis: Substance Abuse and Mental Illness and a review of the major PSYCHIATRIC MEDICINES Mark Stanford, Ph.D. Santa Clara Valley Health & Hospital System Department of Alcohol & Drug Services

More information

Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University

Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal Alan Poling, Ph.D., BCBA-D Western Michigan University In a 2010 study of 60,641 children Mandell et al. found that: 56%

More information

Introductory discussion

Introductory discussion Billina R. Shaw, MD Assistant Professor University of Maryland School of Medicine Department of Psychiatry Division of Child and Adolescent Psychiatry Introductory discussion Prescribing trends in foster

More information

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious

More information

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Drug List Changes - UPDATE Note: This article was previously published in the December 2014 Medicaid

More information

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S. BRIEF ANTIDEPRESSANT OVERVIEW Casey Gallimore, Pharm.D., M.S. Antidepressant Medication Classes First Generation Tricyclic Antidepressants (TCAs) Monoamine Oxidase Inhibitors (MAOIs) Second Generation

More information

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS

CENPATICO INTEGRATED CARE BEHAVIORAL HEALTH DRUG LIST BY DRUG CLASS ANTIDEPRESSANTS ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS MIRTAZAPINE ODT TABLETS 15 MG REMERON SOL 90 30 MIRTAZAPINE ODT TABLETS 30 MG REMERON SOL 45 30 MIRTAZAPINE ODT TABLETS 45 MG REMERON SOL 30

More information

Psychobiology Handout

Psychobiology Handout Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are

More information

Patient History Form

Patient History Form Patient History Form Date: / / NAME: Last First Middle Birthdate: / / Age: Sex: F M Please read the following questions and answer to the best of your ability by placing a check mark in the appropriate

More information

8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation

8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation Managing Psychiatric Conditions in Primary Care Beyond the Basics Source: US National Library of Medicine, Images from the History of Medicine Luis Berrios, DNP, MHA, ANP, PMHNP Internal Medicine & Primary

More information

3/6/2009. Disclosure

3/6/2009. Disclosure Recent Advances in the Psychopharmacologic Treatment of Individuals with Developmental Disabilities Antonio Hardan, M.D. Associate Professor of Psychiatry Director, Autism and Developmental Disabilities

More information

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018 MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES Holly Altenberger, PharmD, RPh Director of Pharmacy O Connell Pharmacy holly@oconnellpharmacy.com Objectives At the conclusion of the

More information

New Patient Information - Adolescent

New Patient Information - Adolescent Scanned Ages 12-17 Dear Parent: To help your clinician understand and help your child, please answer the questions on this form and bring it with you to your child s first appointment. Please print using

More information

Mentoring Session: Participant Cases

Mentoring Session: Participant Cases Handout for the Neuroscience Education Institute (NEI) online activity: Mentoring Session: Participant Cases The Case: 55-year-old patient with depression and anxiety The Question: What to do when antidepressants

More information

ANTI-DEPRESSANT MEDICATIONS

ANTI-DEPRESSANT MEDICATIONS ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change

More information

3/19/18. Medications Used In the Mental Health Care of Children. General Pediatric Psychopharmacology Overview

3/19/18. Medications Used In the Mental Health Care of Children. General Pediatric Psychopharmacology Overview Medications Used In the Mental Health Care of Children American Academy of Pediatrics Critical Issues in School Health March 22 nd 2018 Jennifer Zajac, D.O. Saachi Tarr, M.D. Vanessa Katon, D.O. Institute

More information

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Change Your Brain, Change Your Life The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Daniel G Amen Three Rivers Press New York Appendix Medication 1.

More information

Professional Practice Minutes September 7 th, 2016

Professional Practice Minutes September 7 th, 2016 Professional Practice Minutes September 7 th, 2016 1. Lung Cancer Screening : Fast Facts Number 1 killer of both men and women in the US (The Global Burden of Cancer 2013) More people die from lung cancer

More information

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Abstract: The majority of boys and many girls with fragile X

More information

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents DRUG NAME INDICATIONS / ACCEPTABLE USES PRIOR STIMULANT/ADHD DRUGS Daytrana (methylphenidate) ADHD

More information

Depression. University of Illinois at Chicago College of Nursing

Depression. University of Illinois at Chicago College of Nursing Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors

More information

Psychiatric Issues in Huntington s Disease

Psychiatric Issues in Huntington s Disease Psychiatric Issues in Huntington s Disease Arik Johnson, PsyD HDSA Center of Excellence at UCLA June 24, 2011 26th Annual HDSA Conference Minneapolis, MN The information provided by speakers in workshops,

More information

Autism: Improving Health Care Outcomes

Autism: Improving Health Care Outcomes AUTISM AWARESS CONFERENCE Lewis County Autism Coalition 23 September 2011 Autism: Improving Health Care Outcomes Glenn C. Tripp, M.D. Developmental Behavioral Pediatrics Medical Director, Developmental

More information

U T I L I Z A T I O N E D I T S

U T I L I Z A T I O N E D I T S I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental

More information

UPDATE ON THE OUTPATIENT TREATMENT OF PSYCHIATRIC DISORDERS Amanda J. Williams, MD Grayson & Associates Montgomery, AL

UPDATE ON THE OUTPATIENT TREATMENT OF PSYCHIATRIC DISORDERS Amanda J. Williams, MD Grayson & Associates Montgomery, AL UPDATE ON THE OUTPATIENT TREATMENT OF PSYCHIATRIC DISORDERS Amanda J. Williams, MD Grayson & Associates Montgomery, AL Objectives Differentiate the multiple causes of depressed mood and anxiety, and identify

More information

Common Antidepressant Medications for Adults

Common Antidepressant Medications for Adults (and Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) Fluoxetine Weekly (Prozac Weekly) 20 in AM w/ food (10 mg in elderly or those w/ panic disorder) 20 40 40 (If age >60yo, max 20) 10 10

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information